223
Views
4
CrossRef citations to date
0
Altmetric
Review

Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)

ORCID Icon, , , , ORCID Icon &
Pages 723-738 | Received 25 Sep 2019, Accepted 11 May 2020, Published online: 27 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Paola Rogliani & Mario Cazzola. (2023) Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval. Expert Opinion on Investigational Drugs 32:6, pages 525-536.
Read now

Articles from other publishers (3)

Kaixi Ding, Wei Jiang, Wenling Zhan, Chunping Xiong, Jieling Chen, Yu Wang, Huanan Jia & Ming Lei. (2023) The therapeutic potential of quercetin for cigarette smoking–induced chronic obstructive pulmonary disease: a narrative review. Therapeutic Advances in Respiratory Disease 17, pages 175346662311708.
Crossref
Nicola P. Bondonno, Benjamin H. Parmenter, Frederik Dalgaard, Kevin Murray, Daniel Bech Rasmussen, Cecilie Kyrø, Aedin Cassidy, Catherine P. Bondonno, Joshua R. Lewis, Kevin D. Croft, Gunnar Gislason, Augustin Scalbert, Anne Tjønneland, Kim Overvad, Anja Olsen & Jonathan M. Hodgson. (2022) Flavonoid intakes inversely associate with COPD in smokers. European Respiratory Journal 60:2, pages 2102604.
Crossref
Suxiang Feng, Jie Yuan, Di Zhao, Rongrong Li, Xuefang Liu, Yange Tian & Jiansheng Li. (2022) Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology. PLOS ONE 17:6, pages e0269087.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.